Holen Sie sich die Stockscreener-App
280.84
0.36%
1.00
Handel nachbörslich:
281.30
0.46
+0.16%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$279.84
Offen:
$279.47
24-Stunden-Volumen:
1.99M
Relative Volume:
0.66
Marktkapitalisierung:
$150.87B
Einnahmen:
$33.42B
Nettoeinkommen (Verlust:
$4.09B
KGV:
37.20
EPS:
7.55
Netto-Cashflow:
$10.39B
1W Leistung:
+1.28%
1M Leistung:
-8.48%
6M Leistung:
-11.40%
1J Leistung:
+4.25%
1-Tages-Spanne:
$276.44
$282.19
1-Wochen-Bereich:
$270.36
$283.60
52-Wochen-Spanne:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
280.84 | 150.87B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
884.54 | 794.47B | 45.04B | 10.59B | 414.30M | 11.71 |
|
JNJ
Johnson Johnson
|
154.58 | 370.90B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
186.06 | 301.01B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
62.08 | 258.93B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
112.14 | 218.33B | 51.72B | 11.94B | 13.81B | 5.88 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off - The Motley Fool
State of Tennessee Department of Treasury Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment - simplywall.st
Amgen (AMGN) Invests $900 Million in Ohio Expansion - GuruFocus
Amgen announces $900 million production investment - The Pharma Letter
CSM Advisors LLC Purchases 3,444 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Trimmed by Adage Capital Partners GP L.L.C. - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Has $19.43 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Hancock Whitney Corp Sells 2,474 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Biotech company AMGEN launching a major expansion - nbc4i.com
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Tower Research Capital LLC TRC - MarketBeat
Trajan Wealth LLC Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
GeoWealth Management LLC Sells 1,088 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Lifted by MetLife Investment Management LLC - MarketBeat
Amgen to expand New Albany facility with $900 million investment, 350 new jobs - WTTE
'EXPANDING MANUFACTURING': Amgen CEO unveils exciting investments - Fox Business
Amgen to expand Ohio biotech manufacturing plant - Reuters
Amgen Announces $900 Mln Manufacturing Expansion, Creation Of 350 New Jobs In Ohio - marketscreener.com
Amgen invests $900M to expand Ohio biomanufacturing - Endpoints News
Amgen Pledges $900 Million, Hundreds of Jobs in Ohio Expansion - MSN
Amgen to invest $900 million in New Albany expansion, nearly doubling job creation - The Business Journals
Amgen pledges $900M, hundreds of jobs in Ohio expansion - Crain's Cleveland Business
Amgen (AMGN) Expands Ohio Facility with Additional $900M Investm - GuruFocus
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Bridgewater Associates LP - MarketBeat
Amgen Reports $900 Million Manufacturing Expansion in Ohio - marketscreener.com
New Albany biotech facility announces $900 million expansion - 10tv.com
Amgen's Massive $900M Manufacturing Push Creates 350 Jobs in Strategic Ohio Expansion - Stock Titan
Amgen to spend $900M to expand Ohio drugmaking plant - Seeking Alpha
Headache Disorders Market Detailed in New Research Report By 2032 | Amgen Inc., Allergan (AbbVie Inc.) - openPR.com
EMA Says Tepezza Received Positive CHMP Opinion For Treatment Of Adults With Moderate To Severe Thyroid Eye Disease - marketscreener.com
US pharma tariffs would raise US drug costs by $51 billion annually, report finds - marketscreener.com
Exclusive-US pharma tariffs would raise US drug costs by $51 billion annually, report finds - marketscreener.com
Pinebridge Investments L.P. Buys 86,927 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Buys New Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Curi RMB Capital LLC - MarketBeat
J. Safra Sarasin Holding AG Lowers Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Cut by Cornerstone Capital Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Lessened by Capital Group Private Client Services Inc. - MarketBeat
Capital International Inc. CA Buys 57,347 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Capital Research Global Investors Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Capital World Investors Purchases 6,029,058 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Driving Drug Design Using DNA Encoded Libraries - Amgen
Amgen, Sanofi & Novartis Drive Multiple Myeloma Market Amid US Tariff Dynamics - openPR.com
Piper Sandler maintains overweight on Amgen stock, $329 target - Investing.com
Cantor Fitzgerald Begins Coverage on Amgen (NASDAQ:AMGN) - MarketBeat
Natixis Sells 58,754 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Sells 3,422 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
CANADA LIFE ASSURANCE Co Sells 10,291 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
XTX Topco Ltd Decreases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Capital International Investors Acquires 3,495,503 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Commerce Bank Lowers Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.81%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):